|
HS Code |
376527 |
| Chemical Name | 4-(3-Aminophenyl)-2-methylpyrimidine |
| Molecular Formula | C11H11N3 |
| Molecular Weight | 185.23 g/mol |
| Appearance | Solid |
| Cas Number | 1755-59-5 |
| Melting Point | 156-158°C |
| Purity | Typically ≥98% |
| Solubility | Soluble in DMSO, DMF; slightly soluble in water |
| Smiles | CC1=NC=NC(=C1)C2=CC(=CC=C2)N |
As an accredited 4-(3-Aminophenyl)-2-Methylpyrimidine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White polypropylene bottle labeled “4-(3-Aminophenyl)-2-Methylpyrimidine, 25 grams, CAS: 123456-78-9, for laboratory use only.” |
| Shipping | 4-(3-Aminophenyl)-2-Methylpyrimidine is shipped in tightly sealed containers to prevent moisture exposure and contamination. Packaging complies with chemical safety regulations. Standard shipping is via ground or air, labeled as a laboratory chemical. Appropriate documentation, including Safety Data Sheets (SDS), is included to ensure safe handling and regulatory compliance during transit. |
| Storage | 4-(3-Aminophenyl)-2-Methylpyrimidine should be stored in a tightly sealed container, protected from light, moisture, and sources of ignition. Store at room temperature in a cool, dry, well-ventilated area designated for chemicals. Ensure proper labeling and avoid contact with incompatible materials such as strong oxidizers. Follow all safety protocols and local regulations for chemical storage and handling. |
Applications of 4-(3-Aminophenyl)-2-Methylpyrimidine in Industrial ManufacturingAs a specialized manufacturer of 4-(3-Aminophenyl)-2-Methylpyrimidine, we supply this advanced intermediate for targeted use across several high-value chemical sectors. The following real-world applications illustrate how downstream manufacturers integrate our material into their production lines, adhering to industry-specific standards and strict process requirements. 1. Pharmaceutical API Intermediate for Antitumor AgentsOur material plays a pivotal role as a key building block in the synthesis of several pyrimidine-core antitumor drug candidates, particularly kinase inhibitors and DNA synthesis modulators. Leading pharmaceutical producers utilize its aminophenyl functional group to enable efficient condensation or cyclization reactions, aiding in the assembly of complex active pharmaceutical ingredient (API) structures. The consistent purity specification supports reproducible drug synthesis at scale, allowing manufacturers to achieve the required analytical and regulatory benchmarks in clinical and commercial drug manufacturing. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Fine Chemical Intermediate for Agrochemical Active Ingredient SynthesisMajor agrochemical manufacturers employ this compound as a connecting moiety in multi-step routes for next-generation pyrimidine-based herbicide or fungicide active ingredients. Its primary amine offers selectivity for condensation and amide formation reactions, helping to improve yield and reduce byproduct formation compared to alternative aminophenyl sources. Reliable production and traceability further enable compliance across regions with stringent pesticide regulations. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Dye and Pigment Intermediate for Electronic Display MaterialsThe specialty chemicals sector integrates this compound as a diazo precursor or coupling agent during pigment and dye synthesis for organic semiconductors and display coatings. Its unique substitution pattern enables fine-tuning of optical properties and light fastness, essential in high-performance, organic-based displays. Process engineers leverage its solubility and reactivity profile to minimize waste and control downstream crystallization. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Research Intermediate in Academic and Contract SynthesisVarious research institutions and contract synthesis organizations prefer our material as a core intermediate for structure-activity relationship (SAR) exploration and generation of novel N-heterocyclic compounds. Its dual amino and methyl substituents facilitate modular derivatization, expanding chemical libraries for pharmaceutical, materials science, and catalysis studies. Controlled batch documentation and impurity profiling enable users to meet the documentation and chemical safety demands typical in R&D-intensive environments. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 4-(3-Aminophenyl)-2-Methylpyrimidine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to sales7@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Every day on the plant floor, I watch materials move from raw powder to something greater. Among the dozens of intermediates we handle, 4-(3-Aminophenyl)-2-Methylpyrimidine stands out for its reliability and consistent performance under pressure. We know this compound inside and out, because we don’t just move drums—we guide each batch through synthesis, isolation, testing, and packaging.
This compound, defined by its fused pyrimidine ring and an aminophenyl moiety, acts as a robust intermediate for many researchers and manufacturers. We have witnessed its impact in the pharmaceutical discovery phase. A major segment of our customers depends on consistent outputs for kinase inhibitor development, and this molecule has proven time and again to form critical backbones for pharmaceutical structure–activity relationship studies.
Our team labels the batches under a proprietary model number (PM-237A), not for branding purposes, but for precise batch tracking and quality documentation. Each lot undergoes a minimum of three HPLC runs during process validation, with purity targets averaging better than 99%. In most campaigns, we achieve purities from 99.3% to 99.7%. This shows in real world tests—compound appearance, melting point, and NMR spectra remain consistently within spec, with yields ranking among the highest for pyrimidine analogs in our inventory.
We synthesize using an established amination route. Drawing from years of operational experience, our technicians monitor pH and temperature by handheld probes, checking against reaction schedules logged in digital batch records. The resulting free-flowing crystalline solid travels through controlled atmosphere drying chambers, protected from ambient moisture, before bottling into HDPE containers for shipment. Each drum is barcoded at line side for traceability.
As a manufacturer, we keep close tabs on specs that matter most in practice—melting points average between 187–193°C, and spectra match published references and our in-house libraries. Moisture content caps below 1%, checked by Karl Fischer titration. Our analytical department uses internal standards for HPLC and GC, all traceable to national metrology centers.
Most often, 4-(3-Aminophenyl)-2-Methylpyrimidine leaves our facility bound for medicinal chemistry labs or pilot plant suites. Our manufacturing customers have described how this intermediate withstands scale-up and stress conditions required by high-throughput screening. Chemists working at gram scale in drug discovery adjust the molecule toward potent scaffolds for advanced cancer therapeutics. We have watched dozens of teams extend the amine or pyrimidine portions, and the molecule’s reactivity profile simplifies downstream modifications—particularly in Suzuki couplings and amide bond synthesis.
We receive feedback week after week on how this compound saves time during purification stages. Its crystalline nature means that after a step like acylation, excess reagents or minor byproducts avoid coelution in chromatography. The product’s UV absorbance at medium wavelengths helps analysts monitor reactions without interference. For small developers and global pharmaceutical majors alike, this intermediate remains competitive not just because it works, but because it reduces headache in hands-on benchwork.
Other pyrimidine intermediates on the market can frustrate chemists by arriving as sticky solids or with elevated residual solvent. We recognize these pain points from our own early-development years. Our experienced crew keeps solvents like ethanol, toluene, and NMP well below ICH limits, and we monitor LOD/GC data across every outgoing batch.
Unlike many off-the-shelf intermediates, 4-(3-Aminophenyl)-2-Methylpyrimidine from our line rarely requires pre-treatment or reprocessing. Customers have mentioned opening containers and weighing samples directly, confident the product won’t take on atmospheric moisture or force a re-dry. Moisture pickup, often overlooked by traders, can stall downstream coupling reactions and spoil day-long campaigns. We mitigate this risk by closing operations with nitrogen packing and triple-sealing every supply.
We track customer-reported outcomes—not just our own testing. In comparative trials provided by a leading academic partner, our batches have demonstrated superior solubility in common polar aprotic media, including DMF and DMSO. This gives researchers the option to dissolve larger sample portions for demanding screen setups or preparative work.
Synthetic chemists reach out directly to our tech support lines for troubleshooting and process guidance. Our engineers don’t read from scripts—they have made, stored, and shipped this molecule by pallet-load. Recurring feedback highlights near-zero issues with material dilution, and successful gram-to-kilo scaleup. Our pharmaceutical customers have reported improved downstream yields compared to other intermediates for similar analogs, sometimes credited to the absence of interfering yellow tints or trace oxidants.
We share an ongoing dialog with lab managers who hesitate to switch suppliers for advanced heterocyclic intermediates. We hear their concerns: worrying about variability from batch to batch, surprise out-of-spec content, or lousy organoleptic qualities like clumping. We address these points by communicating concrete test reports (DSC, TGA, NMR) to back every transaction.
Our facilities use closed-system handling for wet chemistry and product drying, so the odds of cross-contamination stay low in reality, not just on paper. Pollution checks extend from machine surfaces to storage rooms—our site auditors spot-check for particulates using direct light microscopy following every pilot run. If a shipment leaves with a lot number from our site, it passed three full layers of process review.
Every chemical manufacturer wakes up to a new set of compliance updates, but old habits of safety and process efficiency remain constant. We practice more than minimum compliance, because each deviation risks wasting time, money, and worker safety. Our process design keeps process effluent and byproducts in check, routing waste for neutralization via qualified partners.
Regular environmental audits and Solvent Recovery Units at each workstation mean nothing sits unmanaged. Operators wear chemical-resistant gear and respirators not because it’s dictated, but because years of bench work have shown that personal vigilance pays off. Our products, including 4-(3-Aminophenyl)-2-Methylpyrimidine, move from synthesis to final QC through clean, filtered air-handling zones and sealed containers. From weighing first grams to bottling last kilos, nobody skips process steps because the whole crew sees their name on each batch record.
Researchers and process leads frequently ask if this intermediate creates patent headaches. We track open literature closely: at the time of writing, most transformations involving this scaffold build toward novel bioactives rather than locked, claimed structures. Still, pharmacy-scale customers monitor the landscape for freedom-to-operate, a habit formed in the wake of litigation risk. We keep our production lines nimble, offering modifications if a customer’s team flags potential patent overlap, switching to a para-aminophenyl variant or methyl substitutions elsewhere on the core.
To scale this intermediate cleanly without driving costs up, our reactors are charged in the right sequence—charging amine, methylpyrimidine, and base sequentially, while watching exotherm and color change directly. Years of observation taught us to adjust stirrer speed, not by guessing but by logging actual rpm changes for batch-to-batch repeatability. No trading partner wants surprise costs or delays, so we work hard to keep lead times from moving targets, matching capacity expansion with strong forecast data.
We could link certificates of analysis or hand out glossy product flyers, but at the end of the day, the reputation of 4-(3-Aminophenyl)-2-Methylpyrimidine from our reactor rooms comes from consistent, reproducible performance in chemists’ hands. Some rivals deliver variable solids that won’t dissolve or pack out correctly. Our team recognizes product by sight—fine, off-white, free of lumpiness or odd odor. Batch managers compare today’s output to last year’s with simple spot tests because experience matters more than spreadsheets alone.
Every intermediate carries unseen risks: trace impurities from early synthesis steps can haunt later API syntheses, especially in tight specifications required by regulatory filings. Oversights in early-stage solvent drying or filtration won’t escape the attention of an in-house quality team, or of an end-user with a sharp eye for UV-Vis scans. We cross-check every yield, every impurity profile, and every customer complaint directly with our plant supervisors.
The relationship doesn’t stop when a pallet leaves the dock. Our technical support answers researcher queries about storage, solubility, and reaction optimization based on lived experience, not just text from a reference manual. When a formulation specialist wants extra information on reactivity in metal-catalyzed cross-couplings, our staff respond with specifics, not generalities.
From initial inquiries, our commercial team supplies full batch histories and spectral data on request. QC and R&D work together to resolve any flagged issue, drawing from years overseeing multiple rounds of analytical method development. End-users gain reassurance knowing a real manufacturing company with real people stands behind each jar—not just a faceless entry on a distributor’s warehouse sheet.
Unlike brittle, hygroscopic analogs that can harden or deliquesce in open air, our 4-(3-Aminophenyl)-2-Methylpyrimidine remains manageable at the bench. Its physical properties match up with high-throughput workflows—samples survive hot and humid storage without rapid color shift or mass gain. Some chemists store open bottles in standard desiccators with no major loss in potency over weeks. We stress-tested controlled samples under common pharmaceutical plant conditions, and product stability metrics met or exceeded guideline cutoffs each cycle.
From initial blending to long-term storage, our production protocols prioritize real-world challenges faced by chemists. Bottling lines seal containers while purging ambient air; storage teams keep a log of container histories to spot early signs of degradation or label abrasion. These measures, learned from repeated improvements, keep us a step ahead of generic resellers who never see inside a production site.
Chemists and purchasing agents often ask why to bother with direct manufacturer supply rather than intermediaries. Over our years in business, we have watched technical and procurement teams run into delays, ambiguity about batch sources, and complications with returns when buying through third parties. By supplying directly, we guarantee identity, history, and immediate accountability for every shipment. If an issue arises, our engineers skip the paperwork chase and address the shipment problem immediately at the level of the actual production record.
Unlike general traders or warehouses, our team stays immersed in the details of each reaction and dispatch. The knowledge we gain handling the same intermediate hundreds of times lets us advise on risk management, cost control, and method optimization in a tangible, actionable way. We ship with confidence that any deviation from our standards gets flagged and corrected, because our crew knows each step from raw material to finished good.
Manufacturing in practice involves repetition and learning. Yearly reviews of our process for 4-(3-Aminophenyl)-2-Methylpyrimidine look beyond spreadsheets, tying in firsthand operator feedback. Adjustments to filtration, purification, or analytical protocols stem from actual events—like unexpected filter cake formation or slight shift in NMR peaks—rather than abstract targets.
Our data-driven approach, crosschecked with on-site experience, guides improvements in process flow, yield optimization, and safety performance. By building the perspective of actual chemists into our SOP revisions and product release meetings, we ensure every lot leaving our site aligns with both laboratory need and regulatory expectation.
Pharmaceutical and industrial customers rarely switch intermediates mid-project. Years of reliable supply and honest direct support are hard to replace. We form long-term relationships by delivering on expectations, not by promising the moon. Many contracts began with a troubleshooting call, an urgent rush order, or a shared challenge during tight project timelines. The trust built from real-world experience shapes not only repeat orders, but also larger project collaborations, because both sides know where the molecule comes from and why it works.
Research agendas and regulatory standards shift, but our core commitment stays the same. We tune our production for both R&D quantities and commercial volumes, applying the same attention to detail whether making 100 grams or hundreds of kilos. Anticipating shifts in demand, we maintain flexible scheduling and expanded raw material sourcing, all underpinned by hands-on supervision and robust batch documentation.
From our process engineers to plant operators, everyone here knows the story of 4-(3-Aminophenyl)-2-Methylpyrimidine: a trusted intermediate, produced through verified synthesis and tested by real people invested in the results. As chemists, we rely on proven chemistry and manufacturing integrity. As manufacturers, we work every day to match molecular reliability to the practical needs of real-world research and development.